Navigated focal laser photocoagulation for central serous chorioretinopathy

Abstract

Jay Chhablani,1 Padmaja Kumari Rani,1 Annie Mathai,1 Subhadra Jalali,1 Igor Kozak2 1Srimati Kanuri Santhamma Vitreo-Retina Service, L V Prasad Eye Institute, Hyderabad, India; 2Division of Vitreoretinal Diseases and Surgery, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia Background and objective: To assess the efficacy of navigated laser (Navilas®) treatment for central serous chorioretinopathy.Materials and methods: Prospective study included 16 eyes of 15 subjects with nonresolving central serous chorioretinopathy. Fluorescein-angiography guided Navilas® treatment was performed. Pre- and posttreatment best-corrected visual acuity, pre- and posttreatment central macular thickness, number of leaks on fluorescein angiography, and various treatment parameters were analyzed. Pain experience was evaluated using the visual analog pain scale.Results: Sixteen eyes from 15 subjects (mean age 42.2±9.9 years) were analyzed. Mean duration of symptoms was 11.45±6.6 months. Average number of leaks per eye was 2.8 and one laser spot per leak was performed. There was complete resolution of subretinal fluid in 15 out of 16 eyes at 2 months. Average visual analog pain scale score was 0.63±1.41. Conclusion: Navilas® without a contact lens achieved resolution of subretinal fluid with a single laser spot for each single leak and minimum iatrogenic damage. Keywords: navigated laser, Navilas®